|1.||Ferragud, A: 1 article (07/2010)|
|2.||Murga, J: 1 article (07/2010)|
|3.||Cardá, M: 1 article (07/2010)|
|4.||Velázquez-Sánchez, C: 1 article (07/2010)|
|5.||Canales, J J: 1 article (07/2010)|
|1.||Cocaine-Related Disorders (Cocaine Addiction)
07/01/2010 - "The present findings indicate that JHW 007 exposure counteracts some critical behavioural correlates of cocaine treatment, including conditioned reward, locomotor stimulation and sensitization, and lend support to the further development of BZT analogues as potential replacement medications in cocaine addiction."
07/01/2010 - "We examined in mice the behavioural effects of (N-(n-butyl)-3alpha-[bis(4'-fluorophenyl)methoxy]-tropane) (JHW 007), a benztropine (BZT) analogue that blocks dopamine uptake, and assessed its potential to influence the actions of cocaine in clinically-relevant models of cocaine addiction. "
|2.||Cocaine (Cocaine HCl)